Fig. 3
(A) DFS and (B) OS for PORT vs. non-PORT in EGFR wild-type patients. (C) DFS and (D) OS for PORT vs. non-PORT in EGFR mutant patients
Fig. 3 | BMC Cancer
(A) DFS and (B) OS for PORT vs. non-PORT in EGFR wild-type patients. (C) DFS and (D) OS for PORT vs. non-PORT in EGFR mutant patients